Stay updated on Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page content or structure. This change does not alter the study data or how a user interacts with the study record.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision label on the page footer changed from v3.6.0 to v3.6.2, indicating a newer page release. This reflects a minor update to the page tooling or formatting and does not imply a change to the study data or eligibility details.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows a recruitment notice 'No longer looking for participants' and adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) alongside an updated Intervention/Treatment label. The older 'Intervention / Treatment' text and 'Revision: v3.5.5' have been removed, with the page revision updated to v3.6.0.SummaryDifference0.5%

- Check36 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small page/template update. No study content or user-facing details have been changed.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision tag updated to v3.5.4, indicating a software/documentation update, replacing the previous v3.5.3. No visible study content or page functionality changes are indicated.SummaryDifference0.1%

- Check80 days agoChange DetectedUpdated the site’s release/revision label for the ClinicalTrials.gov page from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab in Small Cell Lung Cancer Clinical Trial page.